Search

everythinglearnresearchcommunity

for

Search:↓

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

NFATc1 is crucial for keeping hair follicle stem cells inactive.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Dermal papilla microtissues could be useful for initial hair growth drug testing.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Methotrexate is best for lichen planopilaris, and retinoids are best for frontal fibrosing alopecia, but side effects are common.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.